{"id":"https://openalex.org/W2375770443","doi":null,"title":"Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy.","display_name":"Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy.","publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W2375770443","mag":"2375770443","pmid":"https://pubmed.ncbi.nlm.nih.gov/10363619"},"language":"en","primary_location":{"id":"pmid:10363619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030753109","display_name":"Ulrich Schwantes","orcid":"https://orcid.org/0000-0001-5319-5292","observed_orcids":["https://orcid.org/0000-0001-5319-5292"]},"institutions":[{"id":"https://openalex.org/I4210092379","display_name":"Dr. Pfleger Arzneimittel (Germany)","ror":"https://ror.org/00jhkj736","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210092379"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U Schwantes","raw_affiliation_strings":["Department of Medical Science and Clinical Research, Dr. R. Pfleger GmbH, Bamberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Science and Clinical Research, Dr. R. Pfleger GmbH, Bamberg, Germany","institution_ids":["https://openalex.org/I4210092379"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077206776","display_name":"P Topfmeier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Topfmeier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0331,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.86330935,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"37","issue":"5","first_page":"209","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.984000027179718},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/detrusor-overactivity","display_name":"detrusor overactivity","score":0.949999988079071},{"id":"https://openalex.org/keywords/neurogenic-detrusor-overactivity","display_name":"neurogenic detrusor overactivity","score":0.9739999771118164},{"id":"https://openalex.org/keywords/neurogenic-bladder","display_name":"neurogenic bladder","score":0.6769999861717224},{"id":"https://openalex.org/keywords/muscarinic-receptor-selectivity","display_name":"muscarinic receptor selectivity","score":0.9139999747276306},{"id":"https://openalex.org/keywords/organ-selectivity","display_name":"organ selectivity","score":0.8960000276565552},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.878000020980835},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.9769999980926514},{"id":"https://openalex.org/keywords/propiverine","display_name":"propiverine","score":0.8069999814033508},{"id":"https://openalex.org/keywords/tolterodine","display_name":"tolterodine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/trospium-chloride","display_name":"trospium chloride","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oxybutynin","display_name":"oxybutynin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tertiary-amines","display_name":"tertiary amines","score":0.8199999928474426},{"id":"https://openalex.org/keywords/quaternary-ammonium-salts","display_name":"quaternary ammonium compounds","score":0.9660000205039978},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8489999771118164},{"id":"https://openalex.org/keywords/intravesical-drug-delivery","display_name":"intravesical drug delivery","score":0.8169999718666077}],"concepts":[{"id":"https://openalex.org/C2781020410","wikidata":"https://www.wikidata.org/wiki/Q424312","display_name":"Tolterodine","level":4,"score":0.9464380741119385},{"id":"https://openalex.org/C2777844464","wikidata":"https://www.wikidata.org/wiki/Q1060922","display_name":"Oxybutynin","level":4,"score":0.5661930441856384},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5345237851142883},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5332873463630676},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.23720508813858032},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012021","descriptor_name":"Reflex, Abnormal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014570","descriptor_name":"Urologic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10363619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"mag:2375770443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2184448642","https://openalex.org/W4252724369","https://openalex.org/W2892640880","https://openalex.org/W2053187579","https://openalex.org/W1973736267","https://openalex.org/W1991953018","https://openalex.org/W7015865611","https://openalex.org/W2129919419","https://openalex.org/W2069813136","https://openalex.org/W1994609492"],"abstract_inverted_index":{"BACKGROUND:":[0],"Antimuscarinic":[1],"side-effects":[2],"are":[3,154,217,267,274],"relatively":[4],"frequent":[5],"problems":[6],"in":[7,27,56,108,143,251],"oral":[8,111],"pharmacotherapy":[9],"of":[10,16,21,36,51,73,95,110,131,141,151,165,174,177,187,189,230,248,275,286],"detrusor":[11],"instability":[12],"and":[13,48,66,100,121,133,145,194,215,238,259,278,289],"neurogenic":[14],"dysfunction":[15],"the":[17,34,41,46,52,60,82,88,105,129,149,182,210,284],"urinary":[18],"bladder.":[19],"Results":[20],"recent":[22],"clinical":[23,43,260,276],"trials":[24],"demonstrate":[25],"differences":[26,142,269],"tolerance":[28,65,109,150,160,188],"between":[29,270],"antimuscarinic":[30,54,74,112,152,166,249,271],"drugs.":[31],"It":[32],"is":[33],"purpose":[35],"this":[37,63],"paper":[38],"to":[39,45,58,67,169,198,202],"relate":[40],"available":[42,83],"data":[44,261],"pharmacological":[47,179,258],"physicochemical":[49,126,146],"properties":[50,147,180],"different":[53,206],"drugs,":[55,272],"order":[57],"discuss":[59],"reasons":[61],"for":[62,71,245,283],"enhanced":[64],"make":[68],"possible":[69,280],"modes":[70],"improvement":[72,247],"therapy":[75,250],"plainly":[76],"visible.":[77],"METHODS:":[78],"Therefore,":[79],"we":[80],"reviewed":[81],"literature":[84],"using":[85],"among":[86],"others":[87],"computerized":[89],"library":[90],"systems":[91],"Medline":[92],"(National":[93],"Library":[94],"Medicine,":[96],"Bethesda,":[97],"Maryland,":[98],"USA)":[99],"Embase":[101],"(Excerpta":[102],"Medica,":[103],"Amsterdam,":[104],"Netherlands).":[106],"Differences":[107],"drugs":[113,153,167,288],"may":[114,228],"result":[115,173],"from":[116,208,257],"muscarine-receptor":[117],"selectivity,":[118,120],"organ":[119,134],"pharmacokinetic":[122],"as":[123,125,161,163],"well":[124,162],"properties.":[127],"While":[128],"roles":[130],"m-receptor":[132],"selectivity":[135],"need":[136],"more":[137,155],"detailed":[138],"clarification,":[139],"influences":[140],"bioavailability":[144],"on":[148],"sufficiently":[156],"investigated.":[157],"RESULTS:":[158],"Generally,":[159],"efficacy":[164],"seem":[168],"be":[170,203,229],"a":[171,175,223],"complex":[172],"combination":[176],"various":[178],"distinguishing":[181],"individual":[183],"substances.":[184],"The":[185],"enhancement":[186],"propiverine":[190,214],"hydrochloride,":[191],"tolterodine":[192,216],"tartrate":[193],"trospium":[195,220],"chloride":[196,200,221],"compared":[197],"oxybutynin":[199],"seems":[201],"reached":[204],"by":[205],"modes,":[207],"which":[209,273],"molecular":[211],"structure":[212,226],"--":[213,227],"tertiary":[218],"amines,":[219],"possesses":[222],"quarternary":[224],"ammonium":[225],"great":[231],"importance.":[232],"First":[233],"investigations":[234],"with":[235],"alternative":[236],"transdermal":[237],"intravesical":[239],"application":[240,290],"routes":[241],"show":[242],"interesting":[243],"possibilities":[244],"further":[246],"urological":[252],"indications.":[253],"CONCLUSION:":[254],"In":[255],"conclusion,":[256],"it":[262],"becomes":[263],"obvious":[264],"that":[265],"there":[266],"significant":[268],"relevance":[277],"include":[279],"starting":[281],"points":[282],"development":[285],"new":[287],"forms.":[291]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}